Difference between revisions of "Part:BBa K3733040:Design"

(References)
(References)
 
Line 16: Line 16:
  
 
===References===
 
===References===
Zhang L, Wei X, Zhang R, et al. Design and development of a novel peptide for treating intestinal inflammation[J]. Frontiers in immunology, 2019, 10: 1841.
+
Zhang L, Wei X, Zhang R, et al. Design and development of a novel peptide for treating intestinal inflammation[J]. Frontiers in immunology, 2019, 10: 1841.

Latest revision as of 20:37, 1 October 2021


Antimicrobial peptide LTA with signal peptide and affinity tags


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    COMPATIBLE WITH RFC[12]
  • 21
    COMPATIBLE WITH RFC[21]
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    COMPATIBLE WITH RFC[25]
  • 1000
    COMPATIBLE WITH RFC[1000]


Design Notes

Codon optimization is conducted base on Escherichia coli codon bias.


Source

The original sequence of LTA is determined by Zhang, Lulu, et al. (2019)

References

Zhang L, Wei X, Zhang R, et al. Design and development of a novel peptide for treating intestinal inflammation[J]. Frontiers in immunology, 2019, 10: 1841.